Wednesday, June 10, 2026

biotech · Fabry Disease (X-linked lysosomal storage disease). · Kidney Transplant Rejection · SGMO

SANGAMO THERAPEUTICS

News and analysis for SANGAMO THERAPEUTICS on NovaPharmaNews — regulatory, clinical, and market coverage.

7000 Marina Blvd, Brisbane, California 94005, US HQ
1995 Founded
266 Employees
Public company Type
SGMO · NYSE Ticker
Company details
Status
Public
HQ
7000 Marina Blvd, Brisbane, California 94005, US
Founded
1995
Employees
266
Programs
25
Drugs
14
Patents
192
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning SANGAMO THERAPEUTICS — regulatory, clinical, and market coverage.

News and analysis for SANGAMO THERAPEUTICS on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning SANGAMO THERAPEUTICS yet.

Back to company overview →